United States Negative Pressure Wound Therapy Market

United States Negative Pressure Wound Therapy Market Analysis

The United States Negative Pressure Wound Therapy Market size is estimated at USD 1.48 billion in 2025, and is expected to reach USD 1.95 billion by 2030, at a CAGR of 5.7% during the forecast period (2025-2030).

The major factors driving the market growth include the increasing number of accidents and traumatic events, the rising incidence of chronic wounds such as diabetic foot, and technological advancements in NPWT devices. Fatal road crashes often result in severe injuries and traumatic wounds that require advanced wound care techniques like NPWT for effective management. As the number of road accidents and trauma cases in the United States increases, the demand for NPWT devices and services is projected to increase during the forecast period.

For instance, according to the data released by the National Highway Traffic Safety Administration in April 2024, a total of 40,990 cases of fatal road crashes were recorded in the United States in 2023. In addition, the rising number of firework-related injuries in the United States is leading to an increase in burn cases, which is driving the demand for NPWT devices. For instance, according to the Fireworks Annual Report published by the United States Consumer Product Safety Commission in June 2023, there were an estimated 38% of emergency department-treated burn injuries in the United States in 2022. As per the same source, contusions and lacerations accounted for approximately 30% of emergency department-treated injuries in the United States in 2022. Therefore, the high incidence of road accidents and traumatic events in the country is projected to accelerate market growth during the forecast period. Moreover, the presence of prominent players in the country and their active participation in the launch of novel NPWT devices is also projected to drive market growth during the forecast period. For instance, in April 2023, 3M received the United States Food and Drug Administration (FDA) approval for its 3M Veraflo Therapy, which is an NPWT dressing intended for hydromechanical removal of infectious materials, non-viable tissue, and wound debris.

Therefore, factors such as the increasing number of accidents and traumatic events and technological advancements in NPWT devices are projected to drive the growth of the United States Negative Pressure Wound Therapy Market during the forecast period. However, factors like the high cost of the devices & treatment and complications associated with the NPWT device may impede the market growth.

United States Negative Pressure Wound Therapy Market Trends

The Single-use Device Segment is Expected to Show Significant Growth Over the Forecast Period

• Single-use NPWT devices are highly preferred in healthcare settings for infection prevention since they are highly convenient compared to reusable devices. These devices eliminate the need for sterilization and maintenance, saving time and resources. The major factors driving the segment growth include the high prevalence of sports injuries and chronic wounds, the presence of various wound care clinics in the country, and the active participation of prominent players in novel product launches.
• The growing sports injuries in the country are projected to fuel the segment growth over the forecast period. For instance, as per the September 2023 update from Johns Hopkins Sports Injury Statistics, in the United States, about 30.0 million children and teens participate in some form of organized sports, and more than 3.5 million suffer from various injuries every year. In addition, a large proportion of the people in the United States suffer from various chronic wounds every year, which is estimated to drive the demand for single-use NPWT devices during the forecast period. For instance, according to the article published by the American Academy of Home Care Medicine (AAHCM) in September 2022, around 6.5 million people, or 1 in 38 adults, are affected by chronic wounds in the United States every year. As per the same source, the estimated annual cost estimates for managing chronic wounds in the United States range from USD 28.1 billion to USD 96.8 billion. Therefore, the high proportion of people suffering from chronic wounds in the country is projected to drive the demand for single-use NPWT devices for effective wound care.
• Furthermore, the presence of numerous wound care clinics in the country is projected to drive segment growth during the forecast period by increasing the availability of single-use NPWT devices in the nation. For instance, according to the article published by the Dermatology Times in October 2022, currently, there are approximately 2,200 specialty wound care clinics in the United States, with nearly 2,000 associated with hospitals. The remaining ones are private practices focused exclusively on wound care. Thus, the presence of various wound care clinics in the country is projected to accelerate the segment growth during the forecast period.
• Moreover, the active participation of prominent players in the launch of advanced NPWT devices in the country is projected to drive segment growth during the forecast period. For instance, in May 2023, Smith+Nephew received an innovative technology contract from Vizient for PICO Single Use Negative Pressure Wound Therapy Systems in the United States.
• Therefore, factors such as the high prevalence of sports injuries and chronic wounds, the presence of various wound care clinics in the country, and the active participation of prominent players in novel product launches are projected to drive segment growth during the forecast period. Negative pressure wound therapy (NPWT) is a therapeutic technique that uses a suction dressing to remove excess exudate and promote healing in acute or chronic wounds and second and third-degree burns.

The Diabetic Foot Ulcer Segment is Expected to Register a Significant Share of the Market Over the Forecast Period

• The factors driving the growth of the diabetic foot ulcer segment in the United States include the rising prevalence of diabetes and the increasing geriatric population in the country during the forecast period. The United States has seen a steady increase in diabetes cases, which is a significant risk factor for diabetic foot ulcers.
• As the diabetic population grows, the prevalence of foot ulcers also increases, which is driving the need for NPWT treatment. For instance, according to the article published by the Frontiers in Endocrinology Journal in July 2022, the lifetime incidence of foot ulcers in the United States is estimated to be 15%–25% among patients with diabetes.
• In addition, as per the data released by the IDF, in February 2022, approximately 32.2 million people had diabetes in the United States in 2021. The number is expected to increase to 34.7 million in 2030 and 36.2 million by the end of 2045. Similarly, as per the data released by the CDC in April 2023, approximately 37.3 million, or about 1 in 10 Americans, currently have diabetes. Thus, the rising prevalence of diabetes in the country is projected to drive the segment growth during the forecast period.
• Furthermore, the aging population is more susceptible to chronic conditions like diabetes. With a larger elderly demographic, there is a higher incidence of diabetic foot ulcers, contributing to the growth of this market segment. For instance, as per the data published by the Administration of Community Living (ACL) in April 2022, the American geriatric population is projected to reach 80.8 million by 2040 and 94.7 million by 2060.
• Therefore, the rising prevalence of diabetes and the increasing geriatric population in the country are projected to drive segment growth during the forecast period.

United States Negative Pressure Wound Therapy Industry Overview

The United States Negative Pressure Wound Therapy market is moderately consolidated due to a few large companies dominating the majority of market share, including 3M, Cardinal Health, Smith & Nephew Plc, McKesson Medical-Surgical Inc., and DeRoyal Industries, Inc., among others.

United States Negative Pressure Wound Therapy Market Leaders

United States Negative Pressure Wound Therapy Market News

• August 2023: Medela expanded its negative pressure wound therapy (NPWT) portfolio by introducing the Invia Integrated Dressing, a sterile dressing designed for various wound types, including closed surgical incisions.
• August 2022: 3M launched the 3M Veraflo Cleanse Choice Complete Dressing Kit along with a software upgrade for the 3M V.A.C. Ulta Therapy Unit. This innovation aims to simplify wound care procedures for clinicians utilizing Veraflo Therapy, a form of negative pressure wound therapy with instillation. The new dressing kit and software upgrade are intended to facilitate quicker and less painful dressing changes compared to previous Veraflo Therapy dressings, enhancing the overall experience for patients undergoing wound care.